References
- National Cancer Information Center. Statistics of cancer [Internet]. Gyeonggido: National Cancer Information Center; 2016 [cited 2017 November 15]. Available from: https://www.cancer.go.kr/lay1/S1T639C641/contents.do
- Seretny M, Currie GL, Sena ES, Ramnarine S, Grant R, MacLeod MR, et al. Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: A systematic review and meta-analysis. Pain. 2014;155(12):2461-2470. https://doi.org/ 10.1016/j.pain.2014.09.020
- Hong JS, Tian J, Wu LH. The influence of chemotherapy-induced neurotoxicity on psychological distress and sleep disturbance in cancer patients. Current Oncology. 2014;21(4):174-180. https://doi.org/10.3747/co.21.1984
- Hershman DL, Lacchetti C, Dworkin RH, Lavoie Smith EM, Bleeker J, Cavaletti G, et al. Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American society of clinical oncology clinical practice guideline. Journal of Clinical Oncology. 2014;32(18):1941-1967. https://doi.org/10.1200/JCO.2013.54.0914
- Kim KY, Lee SH, Kim JH, Oh PJ. Disturbance in ADL from chemotherapy-induced peripheral neuropathy and quality of life in cancer patients: The mediating effect of psychological distress. Journal of Korean Academy of Nursing. 2015;45(5):661-670. https://doi.org/10.4040/jkan.2015.45.5.661
- Kim JH, Lee KM, Jeon MJ, Seol ME, Lee SH, Park J. Symptom and interference of activities of daily living of chemotherapy-induced peripheral neuropathy in patients receiving taxanes and platinums. Asian Oncology Nursing. 2013;13(3):145-151. https://doi.org/10.5388/aon.2013.13.3.145
- Mols F, Beijers T, Lemmens V, van den Hurk CJ, Vreugdenhil G, van de Poll-Franse LV. Chemotherapy-induced neuropathy and its association with quality of life among 2-to 11-year colorectal cancer survivors: Results from the population-based profiles registry. Journal of Clinical Oncology. 2013;31(21):2699-2707. https://doi.org/10.1200/JCO.2013.49.1514
- Cleeland CS, Zhao F, Chang VT, Sloan JA, O'Mara AM, Gilman PB, et al. The symptom burden of cancer: Evidence for a core set of cancer-related and treatment-related symptoms from the eastern cooperative oncology group symptom outcomes and practice patterns study. Cancer. 2013;119(24):4333-4340. https://doi.org/10.1002/cncr.28376
- Kim GD, Jang HJ. Effects of pain, sleep disturbance, and fatigue on the quality of life in patients with pancreatic cancer undergoing chemotherapy. Asian Oncology Nursing. 2012;12(2):117-124. https://doi.org/10.5388/aon.2012.12.2.117
- Tofthagen C, Donovan KA, Morgan MA, Shibata D, Yeh Y. Oxaliplatin-induced peripheral neuropathy's effects on health-related quality of life of colorectal cancer survivors. Supportive Care in Cancer. 2013;21(12):3307-3313. https://doi.org/10.1007/s00520-013-1905-5
- Ancoli-Israel S. Sleep disturbances in cancer: A review. Sleep Medicine Research. 2015;6(2):45-49. https://doi.org/10.17241/smr.2015.6.2.45
- Innominato PF, Spiegel D, Ulusakarya A, Giacchetti S, Bjarnason GA, Levi F, et al. Subjective sleep and overall survival in chemotherapy-naïve patients with metastatic colorectal cancer. Sleep Medicine. 2015;16(3):391-398. https://doi.org/10.1016/j.sleep.2014.10.022
- Irwin MR, Olmstead R, Carroll JE. Sleep disturbance, sleep duration, and inflammation: A systematic review and meta-analysis of cohort studies and experimental sleep deprivation. Biological Psychiatry. 2016;80(1):40-52. https://doi.org/10.1016/j.biopsych.2015.05.014
- Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. International Journal of Cancer. 2014;136(5):E359-E386. https://doi.org/10.1002/ijc.29210
- Shin DW, Sunwoo S, Lee JK. Management of cancer survivors in Korea. Journal of the Korean Medical Association. 2015;58(3):216-226. https://doi.org/10.5124/jkma.2015.58.3.216
- Tofthagen C, McAllister RD, Visovsky C. Peripheral neuropathy caused by paclitaxel and docetaxel: An evaluation and comparison of symptoms. Journal of the Practitioner in Oncology. 2013;4(4):204-215.
- Health Insurance Review & Assessment Service. Evaluate the appropriateness of its stomach cancer. [Internet]. Gangwondo: Health Insurance Review & Assessment Service; 2017 [cited 2017 November 13]. Available from: https://www.hira.or.kr/dummy.do
- Postma TJ, Aaronson NK, Heimans JJ, Muller MJ, Hildebrand JG, Delattre JY, et al. The development of an EORTC quality of life questionnaire to assess chemotherapy-induced peripheral neuropathy: The QLQ-CIPN20. European Journal of Cancer. 2005;41(8):1135-1139. https://doi.org/10.1016/j.ejca.2005.02.012
- Kim JH, Choi KS, Kim TW, Hong YS. Quality of life in colorectal cancer patients with chemotherapy-induced peripheral neuropathy. Journal of Korean Oncology Nursing. 2011;11(3):254-262. https://doi.org/10.5388/jkon.2011.11.3.254
- Buysse DJ, Reynolds CF, Monk TH, Berman SR, Kupfer DJ. The pittsburgh sleep quality index: A new instrument for psychiatric practice and research. Psychiatry Research. 1989;28(2):193-213. https://doi.org/10.1016/0165-1781(89)90047-4
- Jang HS, Choi EO. Factors influencing quality of sleep among patients with colorectal cancer receiving chemotherapy. Asian Oncology Nursing. 2016;16(2):103-111. https://doi.org/10.5388/aon.2016.16.2.103
- Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A, et al. The functional assessment of cancer therapy (FACT) scale: Development and validation of the general measure. Journal of Clinical Oncology. 1993;11(3):570-579. https://doi.org/10.1200/JCO.1993.11.3.570
- Kim HM. Symptoms related to chemotherapy induced peripheral neuropathy. [master's thesis]. Daegu: Keimyung University; 2012. p. 1-34.
- Nishiura M, Tamura A, Nagai H, Matsushima E. Assessment of sleep disturbance in lung cancer patients: Relationship between sleep disturbance and pain, fatigue, quality of life, and psychological distress. Palliative and Supportive Care. 2015;13(3):575-581. https://doi.org/10.1017/S1478951513001119
- Hallworth P, Simpson S, Bennett B, Byrne K, Rider A, Desai T, et al. PCN243-are there differences in Fact-G scores between different tumour types for an EU population using real world data?. Value in Health. 2017;20(9):A456. https://doi.org/10.1016/j.jval.2017.08.325
- Seo JY, Yi M. Distress and quality of life in cancer patients receiving chemotherapy. Asian Oncology Nursing. 2015;15(1):18-27. https://doi.org/10.5388/aon.2015.15.1.18
- Yu R, Deochand C, Krotow A, Leao R, Tong M, Agarwal AR, et al. Tobacco smoke-induced brain white matter myelin dysfunction: Potential co-factor role of smoking in neurodegeneration. Journal of Alzheimer's Disease. 2016;50(1):133-148. https://doi.org/10.3233/JAD-150751
- Oh SY, Shin SW, Koh SJ, Bae SB, Chang H, Kim JH, et al. Multicenter, cross-sectional observational study of the impact of neuropathic pain on quality of life in cancer patients. Supportive Care in Cancer. 2017;25(12):3759-3767. https://doi.org/10.1007/s00520-017-3806-5
- Lee JS, Jeong DU. Sleep and pain. Sleep Medicine and Psychophysiology. 2012;19(2):63-67.
- Jeong JH, Nho JH, Kim GS, Lee YE, Yu SY, Lee HJ, et al. Characteristics and quality of life in gynecologic cancer patients with chemotherapy-induced peripheral neuropathy. Journal of Korean Academy of Women's Health Nursing. 2013;19(4):201-210. https://doi.org/10.4069/kjwhn.2013.19.4.201